BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 21390519)

  • 41. Decreased miR-198 expression and its prognostic significance in human gastric cancer.
    Cui Z; Zheng X; Kong D
    World J Surg Oncol; 2016 Feb; 14():33. PubMed ID: 26852230
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Downregulation of microRNA-100 correlates with tumor progression and poor prognosis in colorectal cancer.
    Chen P; Xi Q; Wang Q; Wei P
    Med Oncol; 2014 Oct; 31(10):235. PubMed ID: 25216869
    [TBL] [Abstract][Full Text] [Related]  

  • 43. MicroRNA-935 acts as a prognostic marker and promotes cell proliferation, migration, and invasion in colorectal cancer.
    Huang Y; Xiao W; Jiang X; Li H
    Cancer Biomark; 2019; 26(2):229-237. PubMed ID: 31524145
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The potential value of miR-1 and miR-374b as biomarkers for colorectal cancer.
    Wu X; Li S; Xu X; Wu S; Chen R; Jiang Q; Li Y; Xu Y
    Int J Clin Exp Pathol; 2015; 8(3):2840-51. PubMed ID: 26045793
    [TBL] [Abstract][Full Text] [Related]  

  • 45. miR-15a-5p, A Novel Prognostic Biomarker, Predicting Recurrent Colorectal Adenocarcinoma.
    Kontos CK; Tsiakanikas P; Avgeris M; Papadopoulos IN; Scorilas A
    Mol Diagn Ther; 2017 Aug; 21(4):453-464. PubMed ID: 28405803
    [TBL] [Abstract][Full Text] [Related]  

  • 46. High expression of serum miR-21 and tumor miR-200c associated with poor prognosis in patients with lung cancer.
    Liu XG; Zhu WY; Huang YY; Ma LN; Zhou SQ; Wang YK; Zeng F; Zhou JH; Zhang YK
    Med Oncol; 2012 Jun; 29(2):618-26. PubMed ID: 21516486
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Association of miR-193b down-regulation and miR-196a up-regulation with clinicopathological features and prognosis in gastric cancer.
    Mu YP; Tang S; Sun WJ; Gao WM; Wang M; Su XL
    Asian Pac J Cancer Prev; 2014; 15(20):8893-900. PubMed ID: 25374225
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The correlation between IGF-II and Bcl-2 expression in colorectal adenocarcinoma.
    Zhang MS; Hu AH; Qiu H; Xiong HH; Chen Y
    Med Oncol; 2012 Jun; 29(2):928-32. PubMed ID: 21380782
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Increased expression of miR-552 acts as a potential predictor biomarker for poor prognosis of colorectal cancer.
    Wang N; Liu W
    Eur Rev Med Pharmacol Sci; 2018 Jan; 22(2):412-416. PubMed ID: 29424898
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Investigation of microRNA-155 as a serum diagnostic and prognostic biomarker for colorectal cancer.
    Lv ZC; Fan YS; Chen HB; Zhao DW
    Tumour Biol; 2015 Mar; 36(3):1619-25. PubMed ID: 25528214
    [TBL] [Abstract][Full Text] [Related]  

  • 51. MicroRNA-9 up-regulation is involved in colorectal cancer metastasis via promoting cell motility.
    Zhu L; Chen H; Zhou D; Li D; Bai R; Zheng S; Ge W
    Med Oncol; 2012 Jun; 29(2):1037-43. PubMed ID: 21562850
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Down-regulation of miR-24-3p in colorectal cancer is associated with malignant behavior.
    Gao Y; Liu Y; Du L; Li J; Qu A; Zhang X; Wang L; Wang C
    Med Oncol; 2015 Jan; 32(1):362. PubMed ID: 25502080
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Decreased expression of semaphorin 3D is associated with genesis and development in colorectal cancer.
    Wang Z; Ding M; Qian N; Song B; Yu J; Tang J; Wang J
    World J Surg Oncol; 2017 Mar; 15(1):67. PubMed ID: 28320475
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Decreased expression of RASSF10 correlates with poor prognosis in patients with colorectal cancer.
    Ma J; Zhang S; Hu Y; Li X; Yuan F; Sun D; Wang L; Zhang F; Chen G; Cui P
    Medicine (Baltimore); 2017 Oct; 96(42):e7011. PubMed ID: 29049167
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Serum miR-19a predicts resistance to FOLFOX chemotherapy in advanced colorectal cancer cases.
    Chen Q; Xia HW; Ge XJ; Zhang YC; Tang QL; Bi F
    Asian Pac J Cancer Prev; 2013; 14(12):7421-6. PubMed ID: 24460313
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Gab2 is a novel prognostic factor for colorectal cancer patients.
    Ding C; Luo J; Yu W; Gao S; Yang L; Chen C; Feng J
    Int J Clin Exp Pathol; 2015; 8(3):2779-86. PubMed ID: 26045784
    [TBL] [Abstract][Full Text] [Related]  

  • 57. MiR-21 regulates biological behavior through the PTEN/PI-3 K/Akt signaling pathway in human colorectal cancer cells.
    Xiong B; Cheng Y; Ma L; Zhang C
    Int J Oncol; 2013 Jan; 42(1):219-28. PubMed ID: 23174819
    [TBL] [Abstract][Full Text] [Related]  

  • 58. MicroRNA-466 (miR-466) functions as a tumor suppressor and prognostic factor in colorectal cancer (CRC).
    Tong F; Ying Y; Pan H; Zhao W; Li H; Zhan X
    Bosn J Basic Med Sci; 2018 Aug; 18(3):252-259. PubMed ID: 29338680
    [TBL] [Abstract][Full Text] [Related]  

  • 59. DNA Hypermethylation of SHISA3 in Colorectal Cancer: An Independent Predictor of Poor Prognosis.
    Tsai MH; Chen WC; Yu SL; Chen CC; Jao TM; Huang CY; Tzeng ST; Yen SJ; Yang YC
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1481-9. PubMed ID: 25968618
    [TBL] [Abstract][Full Text] [Related]  

  • 60. MicroRNA-148b suppresses cell growth by targeting cholecystokinin-2 receptor in colorectal cancer.
    Song Y; Xu Y; Wang Z; Chen Y; Yue Z; Gao P; Xing C; Xu H
    Int J Cancer; 2012 Sep; 131(5):1042-51. PubMed ID: 22020560
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.